Member Company


Hygieia is the developer of the d-Nav® Insulin Management Program. We are a physician practice specializing in insulin therapy management. Hygieia’s AI-driven d-Nav technology is the first and only to earn FDA clearance to automatically adjust insulin doses. Until now, that has been the sole responsibility of physicians. People with type 2 diabetes use the d-Nav program for the safe and effective use of insulin.


Copyright © 2024 Digital Therapeutics Alliance™